Objective:To investigate the mechanism of the effect of Astragalus membranaceus(A.membranaceus)on lung adenocarcinoma at the molecular level to elucidate the specific targets according to the network pharmacology appr...Objective:To investigate the mechanism of the effect of Astragalus membranaceus(A.membranaceus)on lung adenocarcinoma at the molecular level to elucidate the specific targets according to the network pharmacology approach.Methods:The active components of A.membranaceus and their potential targets were col ected from the Traditional Chinese Medicine Systems Pharmacology Database.Lung adenocarcinoma-associated genes were acquired based on Gene Cards,Online Mendelian Inheritance in Man(OMIM),Pharm GKB,and Therapeutic Targets databases.The PI3K/AKT signaling pathway-related genes were obtained using Reactome portal.Networks of"ingredient-target"and"ingredient-target-pathway-disease"were constructed using the Cytoscape3.6.0 software.The relationships among targets were analyzed according protein-protein interaction(PPI)network.Finally,molecular docking was applied to construct the binding conformation between active ingredients and core targets.Cel counting kit 8(CCK8)and Western blot assays were performed to determine the mechanism of the key ingredient of A.membranaceus.Results:A total of 20 active components and their 329 targets,and 7,501 lung adenocarcinoma-related genes and 130 PI3K/AKT signaling pathway-related genes were obtained.According to Venn diagram and PPI network analysis,2 mainly active ingredients,including kaempferol and quercetin,and 6 core targets,including TP53,MAPK1,EGF,AKT1,ERBB2,and EGFR,were identified.The two important active ingredients of A.membranaceus,kaempferol and quercetin,exert the therapeutic effect in lung adenocarcinoma partly by acting on the 6 core targets(TP53,MAPK1,EGF,AKT1,ERBB2,and EGFR)of PI3K/AKT signaling pathway.Expressions of potential targets in lung adenocarcinoma and normal samples were analyzed by using UALCAN portal and found that ERBB2 was overexpressed in lung adenocarcinoma tissues and upregulation of it correlated with clinicopathological characteristics.Final y,quercetin repressed viabilities of lung adenocarcinoma cells by targeting ERBB2 on PI3K/AKT signaling confirmed by CCK8 and Western blot.Conclusion:Our finding unraveled that an active ingredient of A.membranaceus,quercetin,significantly inhibited the lung adenocarcinoma cel s proliferation by repressing ERBB2 level and inactivating the PI3K/AKT signaling pathway.展开更多
基金Supported by the Scientific Research Project of the Affiliated Hospital of Shaanxi University of Chinese Medicine(No.2020MS016)。
文摘Objective:To investigate the mechanism of the effect of Astragalus membranaceus(A.membranaceus)on lung adenocarcinoma at the molecular level to elucidate the specific targets according to the network pharmacology approach.Methods:The active components of A.membranaceus and their potential targets were col ected from the Traditional Chinese Medicine Systems Pharmacology Database.Lung adenocarcinoma-associated genes were acquired based on Gene Cards,Online Mendelian Inheritance in Man(OMIM),Pharm GKB,and Therapeutic Targets databases.The PI3K/AKT signaling pathway-related genes were obtained using Reactome portal.Networks of"ingredient-target"and"ingredient-target-pathway-disease"were constructed using the Cytoscape3.6.0 software.The relationships among targets were analyzed according protein-protein interaction(PPI)network.Finally,molecular docking was applied to construct the binding conformation between active ingredients and core targets.Cel counting kit 8(CCK8)and Western blot assays were performed to determine the mechanism of the key ingredient of A.membranaceus.Results:A total of 20 active components and their 329 targets,and 7,501 lung adenocarcinoma-related genes and 130 PI3K/AKT signaling pathway-related genes were obtained.According to Venn diagram and PPI network analysis,2 mainly active ingredients,including kaempferol and quercetin,and 6 core targets,including TP53,MAPK1,EGF,AKT1,ERBB2,and EGFR,were identified.The two important active ingredients of A.membranaceus,kaempferol and quercetin,exert the therapeutic effect in lung adenocarcinoma partly by acting on the 6 core targets(TP53,MAPK1,EGF,AKT1,ERBB2,and EGFR)of PI3K/AKT signaling pathway.Expressions of potential targets in lung adenocarcinoma and normal samples were analyzed by using UALCAN portal and found that ERBB2 was overexpressed in lung adenocarcinoma tissues and upregulation of it correlated with clinicopathological characteristics.Final y,quercetin repressed viabilities of lung adenocarcinoma cells by targeting ERBB2 on PI3K/AKT signaling confirmed by CCK8 and Western blot.Conclusion:Our finding unraveled that an active ingredient of A.membranaceus,quercetin,significantly inhibited the lung adenocarcinoma cel s proliferation by repressing ERBB2 level and inactivating the PI3K/AKT signaling pathway.
